Clincosm LogoSign in Get a demo

Esophageal Cancer

Showing NaN - NaN of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023

Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)

Recruiting
  • Esophageal Cancer
  • Utidelone and anlotinib
  • Weihui, Henan, China
  • +2 more
May 10, 2023

Esophageal Cancer Trial in Worldwide (Atezolizumab, Tiragolumab, Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • Anyang City, China
  • +68 more
Jan 20, 2023

Esophageal Cancer Trial in Beijing (3DCRT)

Recruiting
  • Esophageal Cancer
  • 3DCRT
  • Beijing, Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Sep 13, 2022

Nutrition Intervention Trials in Linxian Follow-up Study

Enrolling by invitation
  • Esophageal Cancer
  • Gastric Cancer
    • Beijing, China
      Cancer Institute and hospital, Chinese Academy of Medical Scienc
    Aug 24, 2022

    Advanced Solid Cancer, Non Small Cell Lung Cancer, Esophageal Cancer Trial in China (APG-2449)

    Recruiting
    • Advanced Solid Cancer
    • +4 more
    • Beijing, Beijing, China
    • +9 more
    Aug 17, 2022

    Esophageal Cancer, Perioperative Analgesia, NSAIDs Trial in Beijing (Preemptive flurbiprofen axetil, Postoperative flurbiprofen

    Not yet recruiting
    • Esophageal Cancer
    • +4 more
    • Preemptive flurbiprofen axetil
    • +2 more
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Aug 15, 2022

    Adjuvant Radiotherapy for pT1b Esophageal Cancer After

    Completed
    • Esophageal Cancer
      • Beijing, China
        National Cancer Center/Cancer Hospital, Chinese Academy of Medic
      Aug 10, 2022

      Solid Tumor, NSCLC, Cervical Cancer Trial in China (Afuresertib, Nab paclitaxel, Docetaxel)

      Recruiting
      • Solid Tumor
      • +5 more
      • Beijing, Beijing, China
      • +4 more
      Jul 15, 2022

      Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma

      Recruiting
      • Esophageal Cancer
      • Adjuvant Radiotherapy
      • Beijing, Chaoyang, China
        Cancer Institute and Hospital, Chinese Academy of Medical Scienc
      Jul 13, 2022

      NSCLC, Head Neck Cancer, Esophageal Cancer Trial in Beijing (JAB-3068)

      Recruiting
      • Non-small Cell Lung Cancer
      • +3 more
      • Beijing, Beijing, China
      • +4 more
      Mar 11, 2022

      Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

      Recruiting
      • Gastric Cancer
      • +2 more
      • neoantigen tumor vaccine with or without PD-1/L1
      • Beijing, Beijing, China
        PLA General Hospital
      Jan 27, 2022

      Esophageal Cancer Trial in Beijing (AN0025)

      Not yet recruiting
      • Esophageal Cancer
      • Beijing, China
        Chinese PLA General Hospital
      Jan 11, 2022

      Esophageal Cancer, Chemoradiotherapy, Nimotuzumab Trial in Beijing (Radiotherapy, Nimotuzumab, S-1)

      Recruiting
      • Esophageal Cancer
      • +3 more
      • Radiotherapy
      • +2 more
      • Beijing, China
        Department of Radiation Oncology, National Cancer Center/Nationa
      Oct 21, 2021

      Esophageal Cancer, Chemoradiotherapy, Albumin-bound Paxlitaxel Trial in Beijing (Radiotherapy, Albumin-Bound Paclitaxel,

      Recruiting
      • Esophageal Cancer
      • +3 more
      • Radiotherapy
      • +2 more
      • Beijing, China
        Department of Radiation Oncology, National Cancer Center/Nationa
      Aug 16, 2021

      Esophageal Cancer, Chemo Effect, Chemoradiation Trial in Beijing (drug, radiation, procedure)

      Recruiting
      • Esophageal Cancer
      • +6 more
      • Platinum based chemotherapy
      • +6 more
      • Beijing, China
        Department of Radiation Oncology, National Cancer Center/Nationa
      Mar 26, 2021

      Venous Thromboembolism in Patients Undergoing Major Esophageal

      Completed
      • Venous Thromboembolism
      • +2 more
        • Ann Arbor, Michigan
        • +8 more
        Feb 23, 2021

        Esophageal Cancer Trial in Beijing (Nimotuzumab)

        Completed
        • Esophageal Cancer
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Sciences
        Feb 2, 2021

        Radiotherapy in Lung Cancer and Esophageal Cancer

        Recruiting
        • Lung Cancer
        • Esophageal Cancer
          • Beijing, Beijing, China
            Department of Radiation Oncology, Cancer Hospital, Chinese Acade
          Jan 29, 2021

          Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian,

          Completed
          • Esophageal Cancer
            • Beijing, China
              Chinese Academy of Medical Sciences
            Dec 10, 2020

            Esophageal Cancer Trial in Beijing (Camrelizumab)

            Not yet recruiting
            • Esophageal Cancer
            • Beijing, Beijing, China
              Beijing Cancer Hospital
            Nov 1, 2020

            Esophageal Tumors, Esophageal Cancer Trial in Beijing (Adjuvant Chemoradiation, Adjuvant Radiation, Paclitaxel)

            Active, not recruiting
            • Esophageal Neoplasms
            • Esophageal Cancer
            • Adjuvant Chemoradiation
            • +3 more
            • Beijing, Beijing, China
              Cancer Institute and Hospital, Chinese Academy of Medical Scienc
            Apr 2, 2020

            Esophageal Cancer Trial in Beijing (High-dose, Standard-dose)

            Unknown status
            • Esophageal Cancer
            • High-dose
            • Standard-dose
            • Beijing, Beijing, China
              Beijing Cancer Hospital
            May 7, 2019

            PET in Guiding Cervical Lymphadenectomy

            Unknown status
            • Esophageal Cancer
            • positron emission tomography
            • Beijing, Beijing, China
            • +3 more
            Mar 21, 2019